MX361881B - Prediccion y optimizacion de terapia de potasio en suero para terapia de sangre para insuficiencia renal, especialmente hemodialisis domiciliaria. - Google Patents
Prediccion y optimizacion de terapia de potasio en suero para terapia de sangre para insuficiencia renal, especialmente hemodialisis domiciliaria.Info
- Publication number
- MX361881B MX361881B MX2016002083A MX2016002083A MX361881B MX 361881 B MX361881 B MX 361881B MX 2016002083 A MX2016002083 A MX 2016002083A MX 2016002083 A MX2016002083 A MX 2016002083A MX 361881 B MX361881 B MX 361881B
- Authority
- MX
- Mexico
- Prior art keywords
- potassium
- patient
- therapy
- serum potassium
- hemodialysis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1601—Control or regulation
- A61M1/1613—Profiling or modelling of patient or predicted treatment evolution or outcome
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/3403—Regulation parameters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3607—Regulation parameters
- A61M1/3609—Physical characteristics of the blood, e.g. haematocrit, urea
- A61M1/361—Physical characteristics of the blood, e.g. haematocrit, urea before treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3607—Regulation parameters
- A61M1/3609—Physical characteristics of the blood, e.g. haematocrit, urea
- A61M1/3612—Physical characteristics of the blood, e.g. haematocrit, urea after treatment
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/40—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H70/00—ICT specially adapted for the handling or processing of medical references
- G16H70/60—ICT specially adapted for the handling or processing of medical references relating to pathologies
Landscapes
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- General Health & Medical Sciences (AREA)
- Vascular Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Urology & Nephrology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Anesthesiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Primary Health Care (AREA)
- Emergency Medicine (AREA)
- External Artificial Organs (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Abstract
Un método para predecir concentraciones de potasio en suero en un paciente durante la hemodiálisis incluye medir las concentraciones de potasio en suero del paciente durante un tiempo de la sesión de tratamiento de hemodiálisis y una tasa de ultrafiltración calculada mediante una diferencia entre el peso corporal post- y pre-dialítico del paciente durante una sesión de tratamiento de hemodiálisis dividida entre un tiempo total de tratamiento de la sesión de tratamiento y estimar una depuración de movilización del potasio y un volumen de distribución pre-diálisis del potasio para el paciente. Las concentraciones de potasio en suero del paciente pueden entonces predecirse en cualquier momento durante cualquier sesión de tratamiento de hemodiálisis con la depuración de movilización del potasio estimada y el volumen de distribución pre-diálisis del paciente.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/969,162 US9132219B2 (en) | 2010-04-16 | 2013-08-16 | Therapy prediction and optimization of serum potassium for renal failure blood therapy, especially home hemodialysis |
PCT/US2014/050383 WO2015026542A1 (en) | 2013-08-16 | 2014-08-08 | Therapy prediction and optimization of serum potassium for renal failure blood therapy, especially home hemodialysis |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2016002083A MX2016002083A (es) | 2016-06-23 |
MX361881B true MX361881B (es) | 2018-12-18 |
Family
ID=52484047
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2016002083A MX361881B (es) | 2013-08-16 | 2014-08-08 | Prediccion y optimizacion de terapia de potasio en suero para terapia de sangre para insuficiencia renal, especialmente hemodialisis domiciliaria. |
Country Status (7)
Country | Link |
---|---|
EP (2) | EP3229159B1 (es) |
JP (1) | JP6477704B2 (es) |
AU (1) | AU2014309285A1 (es) |
CA (1) | CA2919223A1 (es) |
ES (2) | ES2653716T3 (es) |
MX (1) | MX361881B (es) |
WO (1) | WO2015026542A1 (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20230136673A (ko) * | 2016-04-15 | 2023-09-26 | 백톤 디킨슨 앤드 컴퍼니 | 회전-방지 푸시 탭을 갖는 의료 디바이스 |
JP6716428B2 (ja) | 2016-11-11 | 2020-07-01 | 日機装株式会社 | 血液浄化治療支援システム |
JP6914803B2 (ja) * | 2017-10-17 | 2021-08-04 | 日機装株式会社 | 血液浄化装置 |
JP6997582B2 (ja) | 2017-10-17 | 2022-01-17 | 日機装株式会社 | 血液浄化装置 |
DE102017130548A1 (de) * | 2017-12-19 | 2019-06-19 | Fresenius Medical Care Deutschland Gmbh | Verfahren und Vorrichtungen zum Festlegen eines Behandlungsregimes zum Verändern von Behandlungsparametern beim Dialysieren eines Patienten |
JP2019212249A (ja) * | 2018-06-10 | 2019-12-12 | 大 益満 | プログラム及び情報処理システム |
US20220093231A1 (en) * | 2019-03-11 | 2022-03-24 | Gambro Lundia Ab | Estimating generation rate of substance in dialysis patients |
CA3156801A1 (en) | 2019-10-04 | 2021-04-08 | Fresenius Medical Care Holdings, Inc. | Techniques for determining patient blood characteristics during a dialysis process |
CN117715667A (zh) * | 2021-07-26 | 2024-03-15 | 株式会社Jms | 透析条件设定辅助装置和程序 |
WO2023053266A1 (ja) * | 2021-09-29 | 2023-04-06 | 国立大学法人静岡大学 | 透析情報提供装置及び透析情報提供プログラム |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10339342B3 (de) * | 2003-08-25 | 2005-01-20 | Fresenius Medical Care Deutschland Gmbh | Blutbehandlungsvorrichtung |
JP4548349B2 (ja) * | 2006-01-20 | 2010-09-22 | 株式会社ジェイ・エム・エス | 血液透析装置 |
US8042563B2 (en) | 2007-02-27 | 2011-10-25 | Deka Products Limited Partnership | Cassette system integrated apparatus |
US20080253911A1 (en) | 2007-02-27 | 2008-10-16 | Deka Products Limited Partnership | Pumping Cassette |
US8393690B2 (en) | 2007-02-27 | 2013-03-12 | Deka Products Limited Partnership | Enclosure for a portable hemodialysis system |
US9028691B2 (en) | 2007-02-27 | 2015-05-12 | Deka Products Limited Partnership | Blood circuit assembly for a hemodialysis system |
US20090107335A1 (en) | 2007-02-27 | 2009-04-30 | Deka Products Limited Partnership | Air trap for a medical infusion device |
US8562834B2 (en) | 2007-02-27 | 2013-10-22 | Deka Products Limited Partnership | Modular assembly for a portable hemodialysis system |
US9514283B2 (en) | 2008-07-09 | 2016-12-06 | Baxter International Inc. | Dialysis system having inventory management including online dextrose mixing |
US8168063B2 (en) | 2008-07-09 | 2012-05-01 | Baxter International Inc. | Dialysis system having filtering method for determining therapy prescriptions |
US8062513B2 (en) | 2008-07-09 | 2011-11-22 | Baxter International Inc. | Dialysis system and machine having therapy prescription recall |
US8057679B2 (en) | 2008-07-09 | 2011-11-15 | Baxter International Inc. | Dialysis system having trending and alert generation |
US7981281B2 (en) | 2008-07-09 | 2011-07-19 | Baxter International, Inc. | Dialysis system having regimen generation methodology |
US9132219B2 (en) * | 2010-04-16 | 2015-09-15 | Baxter International Inc. | Therapy prediction and optimization of serum potassium for renal failure blood therapy, especially home hemodialysis |
MX2012012061A (es) * | 2010-04-16 | 2013-06-28 | Baxter Int | Prediccion y optimizacion de terapia para terapia sanguinea de falla renal, especialmente hemodialisis en casa. |
-
2014
- 2014-08-08 AU AU2014309285A patent/AU2014309285A1/en not_active Abandoned
- 2014-08-08 ES ES14755746.6T patent/ES2653716T3/es active Active
- 2014-08-08 MX MX2016002083A patent/MX361881B/es active IP Right Grant
- 2014-08-08 JP JP2016534762A patent/JP6477704B2/ja active Active
- 2014-08-08 EP EP17173110.2A patent/EP3229159B1/en not_active Not-in-force
- 2014-08-08 WO PCT/US2014/050383 patent/WO2015026542A1/en active Application Filing
- 2014-08-08 EP EP14755746.6A patent/EP3033704B1/en not_active Not-in-force
- 2014-08-08 CA CA2919223A patent/CA2919223A1/en not_active Abandoned
- 2014-08-08 ES ES17173110T patent/ES2717130T3/es active Active
Also Published As
Publication number | Publication date |
---|---|
EP3229159B1 (en) | 2018-12-26 |
EP3033704B1 (en) | 2017-10-04 |
JP2016535644A (ja) | 2016-11-17 |
CA2919223A1 (en) | 2015-02-26 |
ES2717130T3 (es) | 2019-06-19 |
AU2014309285A1 (en) | 2016-01-28 |
EP3033704A1 (en) | 2016-06-22 |
ES2653716T3 (es) | 2018-02-08 |
WO2015026542A1 (en) | 2015-02-26 |
MX2016002083A (es) | 2016-06-23 |
EP3229159A1 (en) | 2017-10-11 |
JP6477704B2 (ja) | 2019-03-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX361881B (es) | Prediccion y optimizacion de terapia de potasio en suero para terapia de sangre para insuficiencia renal, especialmente hemodialisis domiciliaria. | |
NZ603010A (en) | Therapy prediction and optimization for renal failure blood therapy, especially home hemodialysis | |
WO2013101292A3 (en) | Fluid volume monitoring for patients with renal disease | |
WO2012135573A3 (en) | Systems and methods for varying blood flow to identify autoregulatory ranges in a patient | |
SG10201600502XA (en) | Methods and kits for predicting the risk of respiratory failure, renal failure or thrombopenia in a septic patient by measuring endocan levels in blood | |
MX2016015737A (es) | Sistema para analizar el relleno vascular durante la ultrafiltracion de impulsos cortos en la hemodialisis. | |
EP3043875A4 (en) | Method to determine body's physiological response to physical exercise for assessing readiness and to provide feedback, and system for implementing the method | |
HUE038959T2 (hu) | Eljárás akut légúti distressz szindrómával (ARDS) összefüggõ biomarkerek kimutatására, illetve eljárás az ARDS betegben történõ kifejlõdésének és kezelésének monitorozására | |
ZA201802977B (en) | Medical arrangements and a method for determining parameters related to insulin therapy, predicting glucose values and for providing insulin dosing recommendations | |
TN2013000472A1 (en) | Induction of immune tolerance by using methotrexate | |
WO2012169892A3 (en) | The use of alkaline phosphatase for preserving renal function | |
EP2836820A4 (en) | DEVICE, METHOD, SYSTEM FOR DETERMINING THE AGGREGATION RATE OF ERYTHROCYTES | |
WO2012145399A3 (en) | Methods of diagnosing cancer in a patient | |
UA86387U (ru) | Способ оценки эффективности лечения больных с артериальной гипертензией, объединенной с метаболическим синдромом | |
MX2014014821A (es) | Biomarcadores de plasma sanguineo para terapias de combinacion con bevacizumab para el tratamiento de cancer de mama. | |
JP2015521041A5 (es) | ||
UA62757U (ru) | Способ прогнозирования адекватности программного гемодиализа у больных с хронической болезнью почек v стадии | |
UA98953U (en) | Method for forecasting polyneuropathy development in patients receiving peritoneal dialysis | |
UA83553U (ru) | Способ прогнозирования развития рецидивирующего течения пиелонефрита | |
UA86357U (ru) | Способ прогнозирования эффективности лечения больных с синдромом сухого глаза на фоне поствариэктомического синдрома | |
PL394270A1 (pl) | Sposób pomiaru przeplywu sredniego w ukladzie krwionosnym, zwlaszcza rzutu minutowego serca | |
UA62777U (ru) | Способ ранней диагностики степени тяжести острой почечной недостаточности разного генеза | |
UA70535U (ru) | Способ диагностики стресс-индуцированной кардиомиопатии у детей | |
UA77612U (ru) | Способ определения степени фиброза печени | |
UA65684U (ru) | Способ определения повышенного уровня сенсибилизации организма |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |